Zhongshan Weiminghai Jisheng Biopharmaceutical

Zhongshan Weiminghai Jisheng Biopharmaceutical is a Chinese biotechnology company focused on the development of innovative biopharmaceutical products, particularly in the field of oncology. The company leverages advanced antibody engineering to create therapeutic candidates targeting well-validated pathways such as PD-1 and VEGF. Based in the Zhongshan Health Technology Industrial Base, the firm aims to address unmet medical needs in cancer treatment through the development of high-quality biologics. Its current efforts are primarily centered on early-stage research and pre-clinical validation of its lead antibody candidates.